----- ----- -----

Acetazolamide Tablets 125,250 mg (USA)

CATEGORY : Allopathy


SUB CATEGORY : Tablets


SUB SUB CATEGORY : Uncoated Tablets


STRENGTH : 125 mg & 250 mg


PHARMACOPOEIAL STATUS : API official in USP/EP/BP & Tablets official in USP/BP.


LABEL CLAIM : Each tablet contains Acetazolamide USP 125 mg & 250 mg


MARKET : USA & EUROPE




Price : ₹0.00 /
1000 Available
Add To Cart

  • General Not Avaliable
    Application form (Hard copy and electronic format) Not Avaliable
    Mfg.lic, -notary copies Not Avaliable
    FSC & COPP- notary copies Not Avaliable
    WHO GMP- notary copies Not Avaliable
    Special Export Permission (If Applicable) Not Avaliable
    Summary of product characteristics, labeling and package leaflet/insert-English Not Avaliable
    Summary of product characteristics Not Avaliable
    Labeling Not Avaliable
    Package leaflet/insert -(Country specific language) Not Avaliable
    Mockups and samples of trade packages (if samples of trade packages are not available – a sample in final immediate (inside) package without final labeling shall be submitted. In this case a sample in final immediate (inside) and secondary (outer) packages should be given additionally as soon as it is available. Further on, for approval of methods of quality control of the medicinal product additional samples, reference substances with batch certificate including date of production, shelf life and storage conditions could be requested. - Country Specific Language Not Avaliable
    Summary of product characteristics approved in manufacturer/applicant country.    (specification of origin of the country) Not Avaliable
    Environmental risk assessment including Standards of the manufacturing facility and effluents treatment details to be mentioned Not Avaliable
  • Table of contents of module-2, module-3, module-4 and module-5 Not Avaliable
    Introduction to CTD Not Avaliable
    General summary on quality Not Avaliable
    DRUG SUBSTANCE (NAME, MANUFACTURER) Avaliable
    General Information Not Avaliable
    Manufacture Avaliable
    Characterization Avaliable
    Control of Drug Substance Not Avaliable
    Reference Standards or Materials Avaliable
    Container Closure System Not Avaliable
    Stability Avaliable
    DRUG PRODUCT (NAME, DOSAGE FORM) Avaliable
    Description and Composition of the Drug Product Avaliable
    Pharmaceutical Development Avaliable
    Manufacture Avaliable
    Control of Excipients Avaliable
    Control of Drug Product Avaliable
    Reference Standards or Materials Avaliable
    Container Closure System Avaliable
    Stability (As per country requirement) Avaliable
    Review of preclinical data Not Avaliable
    Review of clinical data Not Avaliable
    Summary of pre-clinical data Not Avaliable
    Introduction Not Avaliable
    Summary of pharmacological data in text format Not Avaliable
    Brief Summary Not Avaliable
    Primary Pharmacodynamics Not Avaliable
    Secondary Pharmacodynamics Not Avaliable
    Safety Pharmacology
    Pharmacodynamic Drug Interactions Not Avaliable
    Discussion and Conclusions Not Avaliable
    Tables and Figures Not Avaliable
    Summary of pharmacological data in tabular format Not Avaliable
    Summary of pharmacokinetics data in text format Not Avaliable
    Methods of Analysis Not Avaliable
    Absorption Not Avaliable
    Distribution Not Avaliable
    Metabolism (interspecies comparison) Not Avaliable
    Summary of pharmacokinetics data in tabular format Not Avaliable
    Summary of toxicological data in text format Not Avaliable
    Summary of toxicological data in tabular format Not Avaliable
    Summary of clinical data Not Avaliable
    Summary of biopharmaceutical studies and related analytical methods Not Avaliable
    Summary of clinical pharmacology studies Not Avaliable
    Summary of clinical efficacy Not Avaliable
    Summary of clinical safety Not Avaliable
    Copies of used literature sources Not Avaliable
    Short reviews of individual trials Not Avaliable
  • Table of contents Not Avaliable
    Relevant data Not Avaliable
    Medicinal substance (for medicinal products containing more than one medicinal substance an information should be given in full with respect to each of them) Avaliable
    General information Not Avaliable
    Name Avaliable
    Structure Avaliable
    General properties Avaliable
    Manufacturer Not Avaliable
    Manufacturer Not Avaliable
    Description of manufacturing process and its control Not Avaliable
    Control of materials Not Avaliable
    Control of critical stages and intermediate products Not Avaliable
    Process validation and/or its assessment Not Avaliable
    Development of manufacturing process Avaliable
    Characteristics Not Avaliable
    Demonstration of structure and other characteristics Not Avaliable
    Impurities Avaliable
    Control of medicinal substance Avaliable
    Specification Avaliable
    Analytical methods Avaliable
    Validation of analytical methods Not Avaliable
    Batch analysis 3 BATCH COA (VALIDITY) Avaliable
    Substantiation of specification Not Avaliable
    Standard samples or substances 1BATCH COA (VALIDITY)
    Container/closure system Avaliable
    Stability (As per country requirement) Avaliable
    Summary on stability and conclusions Not Avaliable
    Report on post-registration stability study and stability associated obligations
    Stability data Avaliable
    Medicinal product Avaliable
    Description and composition of the medicinal product Avaliable
    Development pharmaceutics Avaliable
    Constituents of the medicinal product Avaliable
    Medicinal substance Avaliable
    Excipients Avaliable
    Medicinal product Avaliable
    Development of composition Avaliable
    Overages Not Avaliable
    Physical and chemical, and biological properties Avaliable
    Development of manufacturing process Avaliable
    Container/closure system Not Avaliable
    Microbiological characteristics Not Avaliable
    Compatibility Avaliable
    Manufacture Avaliable
    Manufacturers Avaliable
    Composition for batch Avaliable
    Description of manufacturing process and process control Not Avaliable
    Control of critical stages and intermediate products Not Avaliable
    Process validation and/or its assessment Not Avaliable
    Control of excipients Avaliable
    Specifications Avaliable
    Analytical methods Avaliable
    Validation of analytical methods Not Avaliable
    Justification of specifications Not Avaliable
    Excipients of human and animal origin Not Avaliable
    New excipients Not Avaliable
    Control of medicinal product Not Avaliable
    Specification (-s) Avaliable
    Analytical methods Avaliable
    Validation of analytical methods Not Avaliable
    Batch analysis Avaliable
    Characteristics of impurities Avaliable
    Substantiation of specification (-s) Not Avaliable
    Standard samples and substances Avaliable
    Container/closure system
    Stability Data Development Stability Data Available for all conditions
    Summary and conclusions on stability studies Avaliable
    Report on post-registration stability study and stability associated obligations Not Avaliable
    Stability data Avaliable
    Amendments Not Avaliable
    Technical devices and facilities Not Avaliable
    Safety assessment of foreign microorganisms Not Avaliable
    New excipients Not Avaliable
    Regional  information Not Avaliable
    Copies of used literature sources Not Avaliable
  • Table of contents Not Avaliable
    Pharmacology Not Avaliable
    Primary pharmacodynamics Not Avaliable
    Secondary pharmacodynamics Not Avaliable
    Safety pharmacology Not Avaliable
    Pharmacodynamic drug interactions Not Avaliable
    Pharmacokinetics Not Avaliable
    Analytical methods and their validation report Not Avaliable
    Absorption Not Avaliable
    Distribution Not Avaliable
    Metabolism Not Avaliable
    Excretion Not Avaliable
    Pharmacokinetic drug interactions (pre-clinical) Not Avaliable
    Other pharmacokinetic studies Not Avaliable
    Toxicology Not Avaliable
    Toxicity after a single dose administration Not Avaliable
    Toxicity after repeated administration Not Avaliable
    Genotoxicity Not Avaliable
    Carcinogenicity Not Avaliable
    Reproductive and ontogenetic toxicity Not Avaliable
    Local tolerance Not Avaliable
    Other toxicity studies Not Avaliable
    Copies of used literature sources Not Avaliable
  • Table of contents Not Avaliable
    List of all clinical trials in tables Not Avaliable
    Report of clinical trials Not Avaliable
    Reports on biopharmaceutical studies Not Avaliable
    Reports on studies related to pharmacokinetics studies with use of human biomaterials Not Avaliable
    Reports on pharmacokinetic studies in human beings Not Avaliable
    Reports on pharmacokinetic studies in human beings Not Avaliable
    Reports on efficacy and safety studies Not Avaliable
    Reports on post-registration experience Not Avaliable
    Samples of individual registration forms and individual lists of patients Not Avaliable
    Copies of used literature sources
    Joint analysis and Registration
    Availability of Any Other Details : (COUNTRY SPECIFIC requirements - Except above mentioned)

Subscribe to get the latest Pharma Trends

We are sure, we dont spam with bulk emails and your email address is safe and will not be shared with any third parties.

Subscribe